Stock Comparison
ARGX vs ASND
argenx NV ADR and Ascendis Pharma AS side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$16.14B
P/E (TTM)
32.7
28.1
Forward P/E
30.4
15.4
Price/Sales
10.0
18.6
Price/Book
6.4
28.7
EV/EBITDA
27.6
-20.0
Dividend Yield
—
—
Profitability
Net Margin
30.44%
58.40%
Operating Margin
27.34%
-0.80%
Return on Equity
23.60%
33.30%
Return on Assets
11.60%
-0.60%
Growth (YoY)
Revenue Growth
59.30%
144.30%
Earnings Growth
95.20%
0.00%
Price & Risk
Beta
-0.0
0.5
52-Week High
$939.68
$277.18
52-Week Low
$652.43
$189.74
Analyst Target
$1,085.78
$309.46
Compare ARGX and ASND your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.